Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2003 | 06-2002 | 06-2001 | 06-2000 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -2,197 | -601 | -1,972 | -2,558 | -2,012 |
| Other Working Capital | -1,707 | -3,327 | -4,808 | 3,602 | -1,151 |
| Other Operating Activity | 4,918 | 5,117 | 704 | 7,078 | 5,300 |
| Operating Cash Flow | $1,014 | $1,189 | $-6,076 | $8,122 | $2,137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,224 | -2,704 | -1,771 | -859 | -183 |
| Net Acquisitions | 32 | -3,823 | -100 | -260 | -25 |
| Investing Cash Flow | $-1,192 | $-6,527 | $-1,871 | $-1,119 | $-208 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,000 | 15,000 | N/A | N/A |
| Debt Repayment | -2,842 | -3,364 | -39,462 | -2,000 | -1,000 |
| Common Stock Issued | N/A | N/A | 27,662 | N/A | N/A |
| Other Financing Activity | -568 | -401 | -486 | -473 | -388 |
| Financing Cash Flow | $-3,410 | $-765 | $2,714 | $-2,473 | $-1,388 |
| Beginning Cash Position | -4,692 | -8,680 | 5,816 | 1,419 | 1,726 |
| End Cash Position | -8,280 | -14,936 | 583 | 5,949 | 2,267 |
| Net Cash Flow | $-3,588 | $-6,103 | $-5,233 | $4,530 | $541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,014 | 1,189 | -6,076 | 8,122 | 2,137 |
| Capital Expenditure | -2,337 | -2,845 | -1,882 | -895 | -253 |
| Free Cash Flow | -1,323 | -1,656 | -7,958 | 7,227 | 1,884 |